PMID: 2507265Oct 1, 1989Paper

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects

Diabetes Care
Matthew C RiddleG Youker

Abstract

Although insulin and sulfonylureas often have additive clinical effects when used in combination for type II (non-insulin-dependent) diabetes, these results are variable and a clinical role for this approach is not yet established. This study tests the efficacy of a specific combined regimen for a subpopulation of patients with a randomized double-masked placebo-controlled crossover design and under conditions similar to those of clinical practice. Twenty subjects with limited duration (less than 15 yr) type II diabetes who were moderately obese (less than 160% ideal wt) and proved imperfectly controlled on 10 mg glyburide twice daily completed two 4-mo crossover protocols, comparing a single injection of NPH insulin in the evening plus 10 mg glyburide in the morning with insulin plus placebo. Insulin dose was adjusted by experienced endocrinologists seeking the best glycemic control consistent with safety. All subjects had glycosylated hemoglobin values less than or equal to 150% of the control mean on combined therapy, and combined therapy was superior to insulin alone (fasting plasma glucose 8.0 +/- 0.3 vs. 11.1 +/- 0.6 mM, P less than .01; glycosylated hemoglobin 9.8 +/- 0.1 vs. 10.6 +/- 0.2%, P less than .01). Despite grea...Continue Reading

Citations

Mar 20, 2003·Current Diabetes Reports·M D Passaro, R E Ratner
Sep 17, 2003·Current Diabetes Reports·Afshin Sasali, Jack L Leahy
Jun 17, 2003·Disease-a-month : DM·Rasa Kazlauskaite, Leon Fogelfeld
Jul 3, 1998·Diabetes Research and Clinical Practice·M N FeinglosD L Bursey
Oct 6, 1997·Endocrinology and Metabolism Clinics of North America·M C Riddle
Nov 26, 2003·Clinics in Podiatric Medicine and Surgery·James BerneneGary Peter Jolly
Mar 1, 1992·Journal of Internal Medicine·T SaneM R Taskinen
Nov 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·D E SeiglerJ S Skyler
Dec 20, 2007·Endocrine Research·Kathleen L Wyne, Pablo F Mora
Feb 1, 1991·Annals of Medicine·T SaneM Välimäki
Mar 1, 1992·The American Journal of the Medical Sciences·M RiddleP McDaniel
Apr 4, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·M J DaviesI G Lawrence
Feb 19, 2004·The American Journal of Medicine·Andrew J Ahmann, Matthew C Riddle
Jan 1, 1991·Diabetes Research and Clinical Practice·M C Riddle
Aug 22, 2006·Metabolism: Clinical and Experimental·Marc S Rendell, Lois Jovanovic
May 1, 1990·Journal of the American Geriatrics Society·R C U'RenM Bennington-Davis
Apr 24, 2001·Diabetes Care·H Yki-Järvinen
Dec 1, 1990·DICP : the Annals of Pharmacotherapy·C D Ponte
Jul 17, 2018·International Journal of Endocrinology and Metabolism·Hengameh AbdiAtieh Amouzegar

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.